TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34119410

Group type: EXPERIMENTAL
Intervention: Kinesio taping with voice therapy
Number of subjects: 30
Study: 32902700

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 119

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 119
Study: 32868182

Group type: EXPERIMENTAL
Intervention: Early on-demand percutaneous catheter drainage (PCD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard management (deferred PCD until walled off)
Number of subjects: 120
Study: 35203045

Group type: EXPERIMENTAL
Intervention: Vitamin K2 (360 µg/d)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 33894665

Group type: EXPERIMENTAL
Intervention: ACTH
Number of subjects: 95

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 95
Study: 32590959

Group type: EXPERIMENTAL
Intervention: Internet-based pain education and exercise program
Number of subjects: 160

Group type: COMPARATOR
Intervention: Online self-management booklet
Number of subjects: 160
Study: 34704817

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM), n=100
Number of subjects: 147

Group type: COMPARATOR
Intervention: Blood glucose monitoring (BGM), n=47
Number of subjects: 147
Study: 34108169

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (10 telephone-based sessions over 16 weeks)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Dietary advice (equivalent dose of telephone-based sessions)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 270

Group type: COMPARATOR
Intervention: Dietary advice
Number of subjects: 270
Study: 32544119

Group type: EXPERIMENTAL
Intervention: Natural topical skin ointment (aloe vera, honey, and peppermint)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Petroleum jelly
Number of subjects: 28
Study: 36228401

Group type: EXPERIMENTAL
Intervention: Nesfatin-1
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Irisin
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Adropin
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Preptin
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 110
Study: 32994552

Group type: EXPERIMENTAL
Intervention: Migalastat treatment
Number of subjects: 97
Study: 34921717

Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) combined with procalcitonin (PCT)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Chest X-Ray (CXR) combined with procalcitonin (PCT)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Chest X-Ray (CXR)
Number of subjects: 194
Study: 32881994

Group type: EXPERIMENTAL
Intervention: C-Reactive Protein (CRP)
Number of subjects: 1678

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT)
Number of subjects: 1678

Group type: EXPERIMENTAL
Intervention: White Blood Count (WBC)
Number of subjects: 1678
Study: 36327435

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholate berberine salt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35915734

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technology
Number of subjects: 94

Group type: COMPARATOR
Intervention: X-ray examination
Number of subjects: 94
Study: 33742478

Group type: EXPERIMENTAL
Intervention: Lay health workers (LHWs) providing injectable contraception services
Number of subjects: 460

Group type: COMPARATOR
Intervention: Clinically trained providers (family welfare workers, FWWs) providing injectable contraception services
Number of subjects: 460
Study: 36371421

Group type: EXPERIMENTAL
Intervention: Group 1 (small and bouncing)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Group 2 (small and non-bouncing)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Group 3 (large and bouncing)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Group 4 (large and non-bouncing)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 84
Study: 32743919

Group type: EXPERIMENTAL
Intervention: Strength-based intervention (14 weekly group sessions and 2 bi-weekly follow-up calls)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Dementia education program (control intervention)
Number of subjects: 372
Study: 34791160

Group type: EXPERIMENTAL
Intervention: Targeted therapy (including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, mineralocorticoid receptor antagonists, and cardiac rehabilitation)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Targeted therapy
Number of subjects: 216
Study: 33605807

Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 14802

Group type: EXPERIMENTAL
Intervention: Higher 25OHD levels
Number of subjects: 14802

Group type: EXPERIMENTAL
Intervention: Obesity lowering 25OHD levels
Number of subjects: 14802

Group type: COMPARATOR
Intervention: Adiponectin
Number of subjects: 14802

Group type: COMPARATOR
Intervention: Leptin
Number of subjects: 14802
Study: 35014961

Group type: EXPERIMENTAL
Intervention: Integrative mHealth
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 32
Study: 32538012

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Peridural blockage
Number of subjects: 151
Study: 34089637

Group type: EXPERIMENTAL
Intervention: Music listening for 30 minutes post-surgery
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 56
Study: 32798144

Group type: EXPERIMENTAL
Intervention: Combined everolimus plus lanreotide therapy
Number of subjects: 250

Group type: COMPARATOR
Intervention: Everolimus monotherapy
Number of subjects: 250
Study: 35589429

Group type: EXPERIMENTAL
Intervention: Home-based prehabilitation program plus nutritional guidance
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard care plus written advice on age-appropriate activity and nutrition
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Home-based prehabilitation program plus nutritional guidance (with ≥80% adherence)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard care plus written advice on age-appropriate activity and nutrition (with ≥80% adherence)
Number of subjects: 204
Study: 33296541

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (GCBT) plus usual care (UC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study: 33881692

Group type: EXPERIMENTAL
Intervention: FYM + P'K'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FYM + P'K' + L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NPK + L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FYM
Number of subjects: 0

Group type: COMPARATOR
Intervention: NPK
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfertilized control
Number of subjects: 0
Study: 33253251

Group type: EXPERIMENTAL
Intervention: Chronic pain patients
Number of subjects: 7165
Study: 35364018

Group type: EXPERIMENTAL
Intervention: Tezepelumab 210 mg subcutaneously every 4 weeks for 48 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo subcutaneously every 4 weeks for 48 weeks
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tezepelumab
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 33376150

Group type: EXPERIMENTAL
Intervention: GSK2798745 (2.4 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: GSK2798745 (5 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 33486061

Group type: EXPERIMENTAL
Intervention: Point Union Bridge (PUB) technique
Number of subjects: 88

Group type: COMPARATOR
Intervention: Double-row suture bridge (DRSB) technique
Number of subjects: 88
Study: 32361032

Group type: EXPERIMENTAL
Intervention: Enhanced Family Therapy (ET)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard cognitive behavioral therapy (CBT) family intervention (ST)
Number of subjects: 62
Study: 35549544

Group type: EXPERIMENTAL
Intervention: Knowledge and Attitudes Toward Hospice and Palliative Care (KAHP) scale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Content validation by ten experts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pragmatic, randomized control trial
Number of subjects: 0
Study: 33063249

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 0
Study: 32295569

Group type: EXPERIMENTAL
Intervention: Active Play in ASP intervention
Number of subjects: 456

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 456
Study: 616361154

Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 36178519

Group type: EXPERIMENTAL
Intervention: Hybrid rapid maxillary expander (RME) and facemask (FM) treatment
Number of subjects: 27
Study: 33199379

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg/mL added to LIA mixture
Number of subjects: 140

Group type: COMPARATOR
Intervention: Saline 0.9% added to LIA mixture
Number of subjects: 140
Study: 32441415

Group type: EXPERIMENTAL
Intervention: Higher levels of interleukin-1 receptor antagonist (IL-1ra)
Number of subjects: 12577

Group type: EXPERIMENTAL
Intervention: Higher levels of interleukin-2 receptor alpha subunit (IL-2rα)
Number of subjects: 12577
Study: 35409959

Group type: EXPERIMENTAL
Intervention: Facilitator group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 66
Study: 34684626

Group type: EXPERIMENTAL
Intervention: Healthy Low-Fat (HLF) diet
Number of subjects: 609

Group type: COMPARATOR
Intervention: Healthy Low-Carbohydrate (HLC) diet
Number of subjects: 609
Study: 33326198

Group type: EXPERIMENTAL
Intervention: Synbiotic group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 60
Study: 36134648

Group type: EXPERIMENTAL
Intervention: Surgery plus chemotherapy (S + CT group)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Surgery alone (S group)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Surgery plus oral chemotherapy (S + CT group)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Surgery plus intravenous chemotherapy (S + CT group)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (S + CT group)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Matched groups (S + CT vs S)
Number of subjects: 331
Study: 34033625

Group type: EXPERIMENTAL
Intervention: Motor Imagery training with 85% of one repetition maximum (85%1RM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Motor Imagery training with optimum power loads (OPL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no additional MI sessions)
Number of subjects: 30
Study: 34941035

Group type: EXPERIMENTAL
Intervention: Nutritional support combined with insulin therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Insulin therapy (Control)
Number of subjects: 64
Study: 32572776

Group type: EXPERIMENTAL
Intervention: Entecavir (0.5 mg, daily) and Fuzheng Huayu Tablet (1.6 g, 3 times a day)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Entecavir (0.5 mg, daily) and Fuzheng Huayu Tablet placebo (1.6 g, 3 times a day)
Number of subjects: 700
Study: 33105376

Group type: EXPERIMENTAL
Intervention: Plyometric jump training (PJT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CONG)
Number of subjects: 24
Study: 616874270

Group type: EXPERIMENTAL
Intervention: CBT-I
Number of subjects: 106

Group type: COMPARATOR
Intervention: Regular treatment
Number of subjects: 106
Study: 34132704

Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia
Number of subjects: 460

Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 460
Study: 34522082

Group type: EXPERIMENTAL
Intervention: Phenylephrine IV bolus (40, 50, 60, 70, or 80 µg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phenylephrine IV bolus (70 µg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phenylephrine IV bolus (60 µg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phenylephrine IV bolus
Number of subjects: 40
Study: 34597388

Group type: EXPERIMENTAL
Intervention: Propionic acid (PA) 500 mg twice daily for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33549311

Group type: EXPERIMENTAL
Intervention: 150 mg/mL by PFS × 1 SC injection
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: 90 mg/mL by PFS × 2 SC injections
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: 150 mg/mL by AI × 1 SC injection
Number of subjects: 226

Group type: COMPARATOR
Intervention: All treatment arms
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg SC delivered by PFS or AI
Number of subjects: 226
Study: 34602393

Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs) administered as intravenous infusion of marrow‐derived autologous MSCs (1×10^6 to 2×10^6/kg) for 8 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Acetyl cysteine (NACys) 600mg orally twice a day for 8 weeks
Number of subjects: 200
Study: 33055247

Group type: EXPERIMENTAL
Intervention: PFMT plus electromyographic biofeedback
Number of subjects: 600

Group type: COMPARATOR
Intervention: PFMT alone
Number of subjects: 600
Study: 34517747

Group type: EXPERIMENTAL
Intervention: Self-stigma reduction programme (psychoeducation, cognitive behavioural therapy and social skills training)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 278
Study: 33755548

Group type: EXPERIMENTAL
Intervention: Full assistive technology and telecare package
Number of subjects: 495

Group type: COMPARATOR
Intervention: Basic assistive technology and telecare package (control)
Number of subjects: 495
Study: 34009201

Group type: EXPERIMENTAL
Intervention: Exposure to wood dust
Number of subjects: 370

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 370
Study: 35961232

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 187
Study: 34080313

Group type: EXPERIMENTAL
Intervention: KMRC011 15 μg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: KMRC011 20 μg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: KMRC011 (5, 10, 15, and 20 μg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: KMRC011 (15 μg and 20 μg)
Number of subjects: 8
Study: 33928209

Group type: EXPERIMENTAL
Intervention: Study regimen targeting aberrant pathway (veliparib with temozolomide, adavosertib with carboplatin, everolimus, trametinib)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control regimen not targeting aberrant pathway (same four regimens as experimental)
Number of subjects: 69
Study: 32876128

Group type: EXPERIMENTAL
Intervention: Active rTMS on the dorsomedial prefrontal cortex (DMPFC)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 14
Study: 36316875

Group type: EXPERIMENTAL
Intervention: Kinesio Tape (KT) with 50% tension
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham group (KT without any tension)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo group (rigid tape without any tension)
Number of subjects: 45
Study: 33886650

Group type: EXPERIMENTAL
Intervention: Glidescope® Core™ with a hyperangulated blade
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: C‐MAC® with a nonangulated Miller blade
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Conventional Miller laryngoscope
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Glidescope® Core™ with a hyperangulated blade (limited experience)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Miller laryngoscope (limited experience)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: C‐MAC® Miller (limited experience)
Number of subjects: 86
Study: 35973716

Group type: EXPERIMENTAL
Intervention: Adaptive Support Ventilation (ASV)
Number of subjects: 20
Study: 34311300

Group type: EXPERIMENTAL
Intervention: Paclitaxel (PTX) 100 mg/m2 on days 1, 8, 15, 22, 29 and 36 of each 49-day cycle
Number of subjects: 78

Group type: COMPARATOR
Intervention: Docetaxel (DTX) 70 mg/m2 on day 1 of each 21-day cycle
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Paclitaxel (PTX)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Docetaxel (DTX)
Number of subjects: 78
Study: 32992268

Group type: EXPERIMENTAL
Intervention: Experiential training (training‐as‐usual plus a one‐session treatment for fear of spiders)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Training-as-usual
Number of subjects: 28
Study: 35409234

Group type: EXPERIMENTAL
Intervention: SSRIs (paroxetine or sertraline)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: miRNAs
Number of subjects: 92
Study: 34684551

Group type: EXPERIMENTAL
Intervention: Eucaloric diet
Number of subjects: 28

Group type: COMPARATOR
Intervention: Ad libitum diet
Number of subjects: 28
Study: 32379631

Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 34417901

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33124759

Group type: EXPERIMENTAL
Intervention: Patient‐Practitioner Orientation Scale (PPOS)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: 2-factor model (sharing and caring dimensions)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Principal Component Analysis (PCA)
Number of subjects: 321
Study: 32175299

Group type: EXPERIMENTAL
Intervention: Pamphlet and fluoride varnish four times a year
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Pamphlet plus six phone call reminders and fluoride varnish four times a year
Number of subjects: 37

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 37
Study: 34470135

Group type: EXPERIMENTAL
Intervention: Telehealth monitoring
Number of subjects: 214

Group type: COMPARATOR
Intervention: Standard outpatient blood pressure monitoring
Number of subjects: 214
Study: 34630601

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 122
Study: 35870801

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training curriculum with four 15-minute monthly didactics on BHAG and MI followed by VR simulations.
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group assessed pediatric respiratory distress with no VR training.
Number of subjects: 55
Study: 34464237

Group type: EXPERIMENTAL
Intervention: PES-guided PEEP
Number of subjects: 200

Group type: COMPARATOR
Intervention: Empirical high PEEP
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: PEEP titrated to end-expiratory transpulmonary pressure near 0 cmH2O
Number of subjects: 200
Study: 34591702

Group type: EXPERIMENTAL
Intervention: Computer-based speech perception in noise training for 6 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Masked text recognition training for 6 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Computer-based visual training (VT) program
Number of subjects: 26
Study: 34047046

Group type: EXPERIMENTAL
Intervention: Osseodensification (OD)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Subtractive drilling (SD)
Number of subjects: 56
Study: 32861110

Group type: EXPERIMENTAL
Intervention: Gynogenetic female Siberian sturgeon (Acipenser baerii)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Molecular analysis based on five microsatellite DNA loci
Number of subjects: 30
Study: 35218666

Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 669

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 669
Study: 34405148

Group type: EXPERIMENTAL
Intervention: Collagen (40 gr/d)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Collagen (40 gr/d) plus Fish Oil (10 ml/d)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 32295574

Group type: EXPERIMENTAL
Intervention: Teachers and student peer-counsellors' attitudes towards abortion and contraceptive use as measured by the SABA and CUS scales.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Focus group discussions (FGDs) conducted with teachers and student peer-counsellors.
Number of subjects: 36
Study: 34796725

Group type: EXPERIMENTAL
Intervention: High-frequency group (26 Hz)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Low-frequency group (13 Hz)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Zero-frequency group (0 Hz)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Berg balance scale
Number of subjects: 78

Group type: COMPARATOR
Intervention: Walking speed
Number of subjects: 78
Study: 32103410

Group type: EXPERIMENTAL
Intervention: STAND (Motivational Interviewing + Behavior Therapy)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 225
Study: 35488029

Group type: EXPERIMENTAL
Intervention: Caregivers' BMI at 12 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caregivers' BMI decrease at 12 months (among Māori participants)
Number of subjects: 0
Study: 32855218

Group type: EXPERIMENTAL
Intervention: Automated closed-loop oxygen administration
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard manual oxygen administration
Number of subjects: 200
Study: 36263182

Group type: EXPERIMENTAL
Intervention: JingYinGuBiao formula (JYGB)
Number of subjects: 885

Group type: COMPARATOR
Intervention: TCM placebo
Number of subjects: 885
Study: 32757636

Group type: EXPERIMENTAL
Intervention: Visual Analog Scale
Number of subjects: 43
Study: 32644867

Group type: EXPERIMENTAL
Intervention: Corneal collagen crosslinking with standard antifungal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard antifungal
Number of subjects: 20
Study: 32497491

Group type: EXPERIMENTAL
Intervention: Long-acting injectable cabotegravir (800 mg given three times at 12 week intervals or 600 mg given five times, administered at one 4 week interval, and every 8 weeks thereafter)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Long-acting injectable cabotegravir
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 34984805

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LCD) with a maximum of 20 E% from carbohydrates
Number of subjects: 71